Apex Biotechnology Corp. Sustainability Profile
Apex Biotechnology Corp., a leading name in the biotechnology sector, is headquartered in Taiwan (TW) and operates extensively across Asia and beyond. Founded in 1995, the company has established itself as a pioneer in the development of innovative diagnostic solutions and laboratory equipment, catering to the needs of healthcare professionals and research institutions. Specialising in high-quality reagents, diagnostic kits, and laboratory instruments, Apex Biotechnology stands out for its commitment to precision and reliability. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. With a focus on advancing healthcare through cutting-edge technology, Apex Biotechnology Corp. continues to be a trusted partner in the global biotechnology landscape.
DitchCarbon Score
How does Apex Biotechnology Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Apex Biotechnology Corp.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Apex Biotechnology Corp.'s reported carbon emissions
Apex Biotechnology Corp., headquartered in Taiwan (TW), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, Apex Biotechnology Corp. has not established any documented reduction targets or initiatives, nor have they made any climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, Apex Biotechnology Corp. may benefit from aligning with established frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) to enhance its climate commitments and transparency.
How Carbon Intensive is Apex Biotechnology Corp.'s Industry?
How Carbon Intensive is Apex Biotechnology Corp.'s Location?
Apex Biotechnology Corp.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Apex Biotechnology Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
